Back
Entrada Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
55
TRDA
Entrada Therapeutics
Last Price:
17.81
Seasonality Move:
-29.61%
Sell
24
SRPT
Sarepta Therapeutics
Last Price:
104.56
Seasonality Move:
19.2%
Buy
55
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy, Sell or Hold?
- The current Entrada Therapeutics [TRDA] share price is $17.85. The Score for TRDA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $104.54. The Score for SRPT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $17.85
The current trend is moderately bearish and TRDA is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $104.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
TRDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 48.42 | Sell |
| Chaikin Money Flow: | -114809 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.96 - 19.02) | Sell |
| Bollinger Bands (100): | (14.84 - 17.78) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.26 | Sell |
| Relative Strength Index (14 RSI): | 23.65 | Sell |
| Chaikin Money Flow: | -560985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (116.63 - 130.41) | Sell |
| Bollinger Bands (100): | (121.79 - 145.63) | Sell |
TRDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.28 | Sell |
| 20-day SMA: | 18.12 | Sell |
| 50-day SMA: | 16.7 | Buy |
| 200-day SMA: | 15.12 | Buy |
| 8-day EMA: | 18.9 | Sell |
| 20-day EMA: | 18.31 | Sell |
| 50-day EMA: | 17.29 | Buy |
| 200-day EMA: | 15.76 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 116.03 | Sell |
| 20-day SMA: | 123.12 | Sell |
| 50-day SMA: | 123.81 | Sell |
| 200-day SMA: | 130.41 | Sell |
| 8-day EMA: | 114.12 | Sell |
| 20-day EMA: | 119.76 | Sell |
| 50-day EMA: | 124.56 | Sell |
| 200-day EMA: | 126.9 | Sell |
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.
Entrada Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||